melagatran has been researched along with otamixaban in 1 studies
| Studies (melagatran) | Trials (melagatran) | Recent Studies (post-2010) (melagatran) | Studies (otamixaban) | Trials (otamixaban) | Recent Studies (post-2010) (otamixaban) |
|---|---|---|---|---|---|
| 185 | 32 | 19 | 32 | 12 | 13 |
| Protein | Taxonomy | melagatran (IC50) | otamixaban (IC50) |
|---|---|---|---|
| Coagulation factor X | Homo sapiens (human) | 0.0008 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Dieri, R; Bloemen, S; Hemker, HC | 1 |
1 other study(ies) available for melagatran and otamixaban
| Article | Year |
|---|---|
Large inter-individual variation of the pharmacodynamic effect of anticoagulant drugs on thrombin generation.
Topics: Anticoagulants; Antithrombin III; Azetidines; Benzylamines; Blood Coagulation Tests; Cyclic N-Oxides; Dermatan Sulfate; Dose-Response Relationship, Drug; Factor Xa; Factor Xa Inhibitors; Heparin; Humans; Oligosaccharides; Pyridines; Thrombin | 2013 |